# Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

> **NCT00479778** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 72 (—)

## Conditions studied

- Postmenopause

## Interventions

- **DRUG:** Bazedoxifene/conjugated estrogens

## Key facts

- **NCT ID:** NCT00479778
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 72 (—)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00479778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00479778, "Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00479778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*